BNMS Autumn Meeting 2026

MDC are attending the BNMS Autumn Meeting in Swansea, from the 24- 25 September 2026.

About BNMS:

Established in 1966, the British Nuclear Medicine Society (BNMS) is the only independent forum devoted to all aspects of Nuclear Medicine.

The BNMS is an organisation concerned with the clinical practice, education, research and development of nuclear medicine within the UK. Membership of the BNMS is open to those who have a substantial interest and involvement in the provision of nuclear medicine services. The Society is a registered charity, which works largely through its members to promote the clinical benefits of the specialty. The official journal of the society is Nuclear Medicine Communications.

MDC’s Dr Benedetta Arno will be giving a talk at the event, please see details below if you’d like to join:

Session: Future prospects for radiopharmaceuticals
Date: Friday 25th September
Time of Session: 12:00
Length of talk: 30 minutes

For more information and to register for the event click here

When: September 24-25 2026

Where: Brangwyn Hall
Guildhall Road South
Swansea SA1 4PE
United Kingdom

Dr Benedetta Arno

Lead Scientist, Biodistribution

Benedetta leads the design, planning, and execution of imaging-driven preclinical programs, delivering high-quality data packages to support biotech and pharmaceutical collaborators.

With deep expertise in molecular and optical imaging techniques, including PET, SPECT, CT, and IVIS, she manages a team of scientists dedicated to investigating the biodistribution, pharmacokinetics, and efficacy of radiopharmaceuticals and other therapeutic modalities.

Holding an MSc in Biomedical Science and a PhD in Molecular Medicine, as well as extensive experience across in vitro, in vivo, and ex vivo studies, she drives innovation through multiple stages of drug discovery and works closely with MDC partners to continuously develop and expand new scientific capabilities.

Dr Juliana Maynard

Head of Translational Imaging

Juliana Maynard is an expert Imaging Scientist specialising in pre-clinical imaging technologies, which ultimately aims to advance innovative drug discovery, bringing medicines to patients, faster.

An enthusiastic, proactive, very committed and hard-working individual Juliana has worked with a broad range of imaging modalities including PET, SPECT, CT, ultrasound and MRI. She has a proven track record of research as evidenced in her publications across a wide range of disease and therapy areas.

She possesses good project management skills and has successfully delivered multiple projects with a strong delivery focus. She enjoys working across boundaries using her interpersonal skills to engage with customers and to “put an idea” into practice. Juliana has been based in the North West since earning her PhD at the University of Edinburgh in 2006.

She worked at the University of Manchester and then spent 9 years in increasingly senior roles at AstraZeneca. On leaving AstraZeneca, Juliana recognised the opportunity that medical imaging can have in improving and accelerating drug discovery and set up the creation of a commercial imaging service offering with the ambition to make this readily available for use across the UK drug discovery community.